| Literature DB >> 33839178 |
Xiaoyan Ge1, Wei Liu2, Ziting Zhang2, Fenglei Xie2, Tengfei Zhao2, Yuanhai Li3.
Abstract
BACKGROUND: Unhealthy teeth can seriously affect general health and increase the risk of death in elderly people. There has been no confirmation of which device is most effective for elderly patients with teeth loss. Therefore, we compared four intubation devices in elderly patients with partial and total tooth loss aiming to reduce risk during anesthesia.Entities:
Keywords: Elderly patients; Endotracheal intubation; Lightwand
Mesh:
Year: 2021 PMID: 33839178 PMCID: PMC9373093 DOI: 10.1016/j.bjane.2021.03.002
Source DB: PubMed Journal: Braz J Anesthesiol ISSN: 0104-0014
Demographic data in four groups.
| Group M (n = 50) | Group G (n = 50) | Group F (n = 50) | Group L (n = 50) | |
|---|---|---|---|---|
| 73.44 ± 5.17 | 72.66 ± 4.67 | 72.94 ± 5.19 | 73.00 ± 5.60 | |
| 23/27 | 25/25 | 24/26 | 21/29 | |
| 23 ± 3.9 | 22 ± 2.7 | 23 ± 2.1 | 23 ± 2.8 | |
| 41/9 | 44/6 | 42/8 | 46/4 |
All data were presented as mean ± SD or numbers, p > 0.05.
Figure 1CONSORT flow diagram.
Changes in Systolic (SBP) and Diastolic (DBP) Blood Pressures, and Heart Rate (HR) in four groups.
| Group | Pre- induction (T0) | Pre-intubation (T1) | Post-intubation (T2) | Minutes post-intubation | ||
|---|---|---|---|---|---|---|
| 1 (T3) | 3 (T4) | 5 (T5) | ||||
| Group M | ||||||
| SBP (mmHg) | 132 ± 10.12 | 113 ± 15.72 | 135 ± 9.36 | 124 ± 13.69 | 115 ± 12.91 | 109 ± 15.38 |
| DBP (mmHg) | 86 ± 10.12 | 73 ± 13.29 | 93 ± 14.12 | 87 ± 14.66 | 82 ± 15.39 | 75 ± 13.34 |
| HR (bpm) | 75 ± 12.54 | 71 ± 12.59 | 92 ± 13.92 | 84 ± 10.22 | 82 ± 11.38 | 80 ± 10.29 |
| Group G | ||||||
| SBP (mmHg) | 129 ± 15.38 | 112 ± 12.72 | 133 ± 16.29 | 125 ± 17.48 | 116 ± 16.25 | 110 ± 18.21 |
| DBP (mmHg) | 84 ± 14.63 | 75 ± 15.27 | 92 ± 14.61 | 85 ± 12.42 | 80 ± 13.21 | 74 ± 15.73 |
| HR (bpm) | 74 ± 13.51 | 71 ± 10.63 | 93 ± 10.91 | 82 ± 9.41 | 82 ± 10.43 | 81 ± 11.40 |
| Group F | ||||||
| SBP (mmHg) | 133 ± 14.29 | 112 ± 16.94 | 132 ± 12.40 | 118 ± 17.25 | 113 ± 14.90 | 109 ± 16.30 |
| DBP (mmHg) | 83 ± 13.53 | 74 ± 14.37 | 91 ± 12.62 | 86 ± 14.85 | 81 ± 15.84 | 73 ± 14.39 |
| HR (bpm) | 76 ± 12.62 | 70 ± 13.82 | 95 ± 11.47 | 81 ± 9.92 | 80 ± 12.34 | 77 ± 13.24 |
| Group L | ||||||
| SBP (mmHg) | 129 ± 16.39 | 114 ± 13.51 | 116 ± 14.32 | 113 ± 16.25 | 110 ± 14.38 | 107 ± 15.23 |
| DBP (mmHg) | 84 ± 15.57 | 75 ± 14.38 | 80 ± 15.41 | 79 ± 16.25 | 76 ± 15.39 | 73 ± 16.18 |
| HR (bpm) | 77 ± 13.05 | 74 ± 11.60 | 82 ± 12.58 | 80 ± 9.03 | 79 ± 12.67 | 78 ± 12.91 |
Group M, Macintosh laryngoscope; Group G, Glidescope; Group F, Fiberoptic bronchoscope; Group L, Lightwand.
p < 0.05 compared to Group M, G and F (Only intergroup significances are showed).
Figure 2(A, B and C) Systolic blood pressure, diastolic blood pressure and heart rate changes, respectively, during the study period. (D and E) Epinephrine and norepinephrine concentrations (nmoL.L-1). (F) Total intubation time using each intubation device, mean ± SD. Group M, Macintosh laryngoscope; Group G, Glidescope; Group F, Fiberoptic bronchoscope; Group L, Lightwand.
Serum catecholamine changes.
| Group M | Group G | Group F | Group L | |||||
|---|---|---|---|---|---|---|---|---|
| E (nmoL.L-1) | NE (nmoL.L-1) | E (nmoL.L-1) | NE (nmoL.L-1) | E (nmoL.L-1) | NE (nmoL.L-1) | E (nmoL.L-1) | NE (nmoL.L-1) | |
| 0.191 ± 0.07 | 1.63 ± 0.35 | 0.228 ± 0.04 | 1.59 ± 0.31 | 0.211 ± 0.07 | 1.69 ± 0.48 | 0.205 ± 0.09 | 1.55 ± 0.32 | |
| 0.124 ± 0.05 | 1.14 ± 0.41 | 0.136 ± 0.09 | 1.03 ± 0.42 | 0.118 ± 0.04 | 1.21 ± 0.30 | 0.137 ± 0.06 | 1.13 ± 0.27 | |
| 0.091 ± 0.008 | 1.43 ± 0.37 | 0.083 ± 0.003 | 1.49 ± 0.26 | 0.092 ± 0.005 | 1.19 ± 0.31 | 0. 101 ± 0.004 | 1.10 ± 0.37 | |
E, Epinephrine; NE, Norepinephrine.
Group M, Macintosh laryngoscope; Group G, Glidescope; Group F, Fiberoptic bronchoscope; Group L, Lightwand.
p < 0.05 compared to Group M, G and F (Only intergroup significances are showed).
Success rate, duration of intubation, and post-operation complications.
| Group M | Group G | Group F | Group L | |
|---|---|---|---|---|
| 10/40 (80%) | 11/39 (82%) | 5/45 (90%) | 3/47 (94%) | |
| 46.24 ± 14.35 | 39.71 ± 11.94 | 41.39 ± 13.28 | 25.47 ± 11.58 | |
| 4/46 (8%) | 3/47 (6%) | 0 | 0 | |
| 12/38 (24%) | 7/43 (12%) | 2/48 (4%) | 3/47 (6%) | |
| 5/45 (10%) | 6/44 (12%) | 5/45 (10%) | 0 | |
| 7/43 (14%) | 5/45 (10%) | 4/46 (8%) | 0 |
Group M, Macintosh laryngoscope; Group G, Glidescope; Group F, Fiberoptic bronchoscope; Group L, Lightwand.
p < 0.05 Group F or L compared to Group M or G (Only intergroup significances are showed).